{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T22:49:51Z","timestamp":1782859791020,"version":"3.54.5"},"reference-count":77,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T00:00:00Z","timestamp":1691452800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["American J Addict"],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background and Objectives<\/jats:title><jats:p>Alcohol use disorder (AUD) is a significant public health concern, with underutilized effective treatments, particularly in special populations. This article summarizes the current evidence and guidelines for treating AUD in special populations.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This article is a literature review that synthesizes the latest research on AUD treatment for special populations. We screened 242 articles and included 57 in our final review.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>There are four food and Drug Administration\u2010approved medications for AUD (MAUD): disulfiram, oral naltrexone, extended\u2010release injectable naltrexone (XR\u2010NTX), and acamprosate. Naltrexone and disulfiram have the potential to cause liver toxicity, and acamprosate should be avoided in patients with severe kidney disease. Psychosocial treatments should be considered first\u2010line for pregnant and nursing patients. Naltrexone is contraindicated in patients on opioids, as it may precipitate acute withdrawal. For patients experiencing homelessness, nonabstinent treatment goals may be more practical, and XR\u2010NTX should be considered to improve adherence. Limited evidence suggests medication can improve AUD treatment outcomes in adolescents and young adults. For patients with poor treatment response despite adequate medication adherence, switching to a different medication and augmentation with psychosocial treatments should be considered.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion and Conclusions<\/jats:title><jats:p>Understanding the unique considerations for special populations with AUD is crucial, and addressing their special needs may improve their treatment outcomes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Scientific Significance<\/jats:title><jats:p>Our study significantly contributes to the existing literature by summarizing crucial information for the treatment of AUD in special populations, highlighting distinct challenges, and emphasizing tailored approaches to improve overall health and well\u2010being.<\/jats:p><\/jats:sec>","DOI":"10.1111\/ajad.13455","type":"journal-article","created":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T09:09:31Z","timestamp":1691485771000},"page":"433-441","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Medication treatment for alcohol use disorder in special populations"],"prefix":"10.1111","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-9917-4637","authenticated-orcid":false,"given":"Aniket","family":"Malhotra","sequence":"first","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences Emory University Atlanta Georgia USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Drexler","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences Emory University Atlanta Georgia USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hsu","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences Emory University Atlanta Georgia USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi\u2010lang","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences Emory University Atlanta Georgia USA"},{"name":"Substance Abuse Treatment Program Joseph Maxwell Cleland Atlanta VA Medical Center Decatur Georgia USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,8,8]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(18)30337-7"},{"key":"e_1_2_5_3_1","unstructured":"World Health Organization. Global status report on alcohol and health 2018. Accessed January 28 2023https:\/\/www.who.int\/publications\/i\/item\/9789241565639"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2017.2161"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2015.01.031"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2008.07.018"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.17.2003"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2012.04054.x"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0087366"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.856938"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2020.00047"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-016-0718-x"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/acer.13944"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31042"},{"key":"e_1_2_5_15_1","volume-title":"Textbook of Substance Use Disorder Treatment","author":"Brady KT","year":"2021"},{"key":"e_1_2_5_16_1","first-page":"2000","volume-title":"Treatment of Alcohol Use Disorder","author":"Mar Y","year":"2020"},{"key":"e_1_2_5_17_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.3628"},{"key":"e_1_2_5_18_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2017.1750101"},{"key":"e_1_2_5_19_1","article-title":"Opioid antagonists for alcohol dependence","volume":"12","author":"R\u00f6sner S","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_5_20_1","article-title":"Acamprosate for alcohol dependence","volume":"9","author":"R\u00f6sner S","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_5_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-020-06073-w"},{"key":"e_1_2_5_22_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.201000553"},{"key":"e_1_2_5_23_1","unstructured":"DURAMED PHARMACEUTICALS INC. REVIA\u00ae (naltrexone hydrochloride) [package insert]. U.S. Food and Drug Administration website. Accessed February 19 2023.https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2013\/018932s017lbl.pdf"},{"key":"e_1_2_5_24_1","unstructured":"Alkermes Inc.VIVITROL\u00ae (naltrexone for extended\u2010release injectable suspension) [package insert]. U.S. Food and Drug Administration website. Accessed February 19 2023.https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2010\/021897s015lbl.pdf"},{"key":"e_1_2_5_25_1","unstructured":"HoltSR.Alcohol use disorder: pharmacologic management. In:SteinMB FriedmanM eds.UpToDate 2023."},{"key":"e_1_2_5_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.2007.00593.x"},{"key":"e_1_2_5_27_1","doi-asserted-by":"publisher","DOI":"10.15288\/jsad.2012.73.991"},{"key":"e_1_2_5_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2014.02.008"},{"key":"e_1_2_5_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.alcohol.2006.05.003"},{"key":"e_1_2_5_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1994.tb04002.x"},{"key":"e_1_2_5_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.2011.01601.x"},{"key":"e_1_2_5_32_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1997.01830240090013"},{"key":"e_1_2_5_33_1","unstructured":"Springer SA.Monitoring of Liver Function Tests in Patients Receiving Naltrexone or Extended\u2010Release Naltrexone. Providers Clinical Support System (PCSS); 2023."},{"issue":"2","key":"e_1_2_5_34_1","first-page":"147","article-title":"Alcoholic liver disease: pathogenesis and current management","volume":"38","author":"Osna NA","year":"2017","journal-title":"Alcohol Res Curr Rev"},{"key":"e_1_2_5_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12070"},{"issue":"6","key":"e_1_2_5_36_1","first-page":"17","article-title":"Clinical pharmacokinetics of gabapentin","volume":"44","author":"McLean MJ","year":"1994","journal-title":"Neurology"},{"key":"e_1_2_5_37_1","unstructured":"LiverTox: Clinical and Research Information on Drug\u2010Induced Liver Injury. National Institute of Diabetes and Digestive and Kidney Diseases; 2012."},{"key":"e_1_2_5_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2014.03.011"},{"key":"e_1_2_5_39_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0000000000000461"},{"key":"e_1_2_5_40_1","unstructured":"Neurontin\u00ae (gabapentin) [package insert] New York NY: Parke Davis;2017. Accessed February 19 2023."},{"key":"e_1_2_5_41_1","doi-asserted-by":"publisher","DOI":"10.1097\/OGX.0000000000000405"},{"key":"e_1_2_5_42_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0153655"},{"key":"e_1_2_5_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/acer.13135"},{"key":"e_1_2_5_44_1","volume-title":"Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk","author":"Briggs GG","year":"2021"},{"key":"e_1_2_5_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2011.02.029"},{"key":"e_1_2_5_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.reprotox.2015.03.003"},{"key":"e_1_2_5_47_1","doi-asserted-by":"publisher","DOI":"10.1002\/bdra.23357"},{"issue":"11","key":"e_1_2_5_48_1","article-title":"Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child","volume":"2017","author":"Weston J","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_5_49_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.14429"},{"key":"e_1_2_5_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2020.01.030"},{"key":"e_1_2_5_51_1","doi-asserted-by":"publisher","DOI":"10.12788\/cp.0327"},{"key":"e_1_2_5_52_1","doi-asserted-by":"publisher","DOI":"10.1001\/archgenpsychiatry.2012.1a"},{"key":"e_1_2_5_53_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2012.03910.x"},{"key":"e_1_2_5_54_1","doi-asserted-by":"publisher","DOI":"10.9740\/mhc.2019.11.392"},{"key":"e_1_2_5_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2014.03.007"},{"key":"e_1_2_5_56_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-019-0137-5"},{"key":"e_1_2_5_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jopan.2022.04.008"},{"key":"e_1_2_5_58_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0050225"},{"key":"e_1_2_5_59_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2014.302248"},{"key":"e_1_2_5_60_1","unstructured":"ZergerS.Substance Abuse Treatment: What Works for Homeless People? A Review of the Literature. National Health Care for the Homeless Council; 2002."},{"key":"e_1_2_5_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2015.02.001"},{"key":"e_1_2_5_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(20)30489-2"},{"key":"e_1_2_5_63_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0254729"},{"key":"e_1_2_5_64_1","doi-asserted-by":"publisher","DOI":"10.1177\/1060028015620800"},{"key":"e_1_2_5_65_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-020-01432-7"},{"key":"e_1_2_5_66_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.13324"},{"key":"e_1_2_5_67_1","unstructured":"National Institute on Alcohol Abuse and Alcoholism.Underage Drinking in the United States. 2023.https:\/\/www.niaaa.nih.gov\/publications\/brochures-and-fact-sheets\/underage-drinking"},{"key":"e_1_2_5_68_1","unstructured":"National Institute on Drug Abuse.Principles of Adolescent Substance Use Disorder Treatment: A Research\u2010Based Guide. NIH; 2014.https:\/\/nida.nih.gov\/sites\/default\/files\/podata_1_17_14.pdf"},{"key":"e_1_2_5_69_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40429-016-0098-7"},{"key":"e_1_2_5_70_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2005.15.723"},{"key":"e_1_2_5_71_1","doi-asserted-by":"publisher","DOI":"10.1111\/adb.12050"},{"key":"e_1_2_5_72_1","doi-asserted-by":"publisher","DOI":"10.1097\/WNF.0000000000000152"},{"key":"e_1_2_5_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0893-133X(99)00147-5"},{"key":"e_1_2_5_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2003.08.009"},{"key":"e_1_2_5_75_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2013.11950"},{"key":"e_1_2_5_76_1","doi-asserted-by":"publisher","DOI":"10.1093\/alcalc\/agl007"},{"key":"e_1_2_5_77_1","doi-asserted-by":"publisher","DOI":"10.1093\/alcalc\/agh093"},{"key":"e_1_2_5_78_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2011.10101436"}],"container-title":["The American Journal on Addictions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajad.13455","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T03:51:46Z","timestamp":1730173906000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ajad.13455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,8]]},"references-count":77,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["10.1111\/ajad.13455"],"URL":"https:\/\/doi.org\/10.1111\/ajad.13455","archive":["Portico"],"relation":{},"ISSN":["1055-0496","1521-0391"],"issn-type":[{"value":"1055-0496","type":"print"},{"value":"1521-0391","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,8]]},"assertion":[{"value":"2023-04-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-07-26","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}